This public procurement record has 1 release in its history.

Award

24 Feb 2025 at 16:38

Summary of the contracting process

The Common Services Agency, also known as NHS National Services Scotland (NSS), has concluded the award stage of a public procurement process titled "Compounded Aseptic Medicines". This procurement, under the industry category of Pharmaceutical Products (CPV code 33600000), pertains to the supply of unlicensed, aseptically compounded, ready-to-use medicines in syringes and infusion bags to NHS Scotland. The framework agreement, spanning twelve months, includes four lots covering various medicines. The procurement process followed a limited method without prior publication of a call for competition due to unforeseen circumstances related to the Covid-19 pandemic, and final contracts were signed on February 24, 2025. Deliveries will cover all entities constituted under the National Health Service (Scotland) Act 1978 and relevant Integrated Joint Boards.

This tender presents significant opportunities for business growth, especially for suppliers in the pharmaceutical sector capable of producing aseptically compounded medicines. It provides substantial financial opportunities, with individual contracts valued at £13,653,346, £1,565,729, £1,064,777, and £5,085,024 respectively. Companies like Baxter Healthcare Ltd, Qualasept Limited t/a Bath ASU, and ITH Pharma Limited are poised to benefit from the framework agreements. The emphasis on ready-to-use medicines in syringes and infusion bags ensures demand continuity, making it an excellent opportunity for businesses specializing in pharmaceutical products to secure long-term supply contracts and establish strong relations with NHS Scotland.

How relevant is this notice?

Notice Title

Compounded Aseptic Medicines

Notice Description

This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland.

Lot Information

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra(r)), (Remicade(r)), (Remsima(r)) Nivolumab Pembrolizumab Pertuzumab The Authority intends to awarded all presentations within this Lot to a single supplier.

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Cyclophosphamide Fluorouracil Irinotecan Methotrexate Rituximab (Mabthera(r)), (Rixathon(r)), (Truxima(r)) The Authority intends to awarded all presentations within this Lot to a single supplier

Compounded Aseptic Medicines

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Bortezomib Carboplatin Cisplatin Docetaxel Gemcitabine Oxaliplatin Trastuzumab (Herceptin(r)), (Herzuma(r)) Vincristine The Authority intends to awarded all presentations within this Lot to a single supplier.

Compounded Aseptic Medicines - All Other Presentations

Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, The molecules included in this Lot are, Bevacizumab Cytarabine Infliximab (Zessly(r)) Insulin Methotrexate Natalizumab Nivolumab Paclitaxel Pemetrexed Tocilizumab Trastuzumab (Kanjinti(r)), (Ontruzant(r)) Trastuzumab Subcutaneous Vedolizumab Each product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework.

Procurement Information

This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04e7a2
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/007093-2025
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£21,368,876 £10M-£100M

Notice Dates

Publication Date
24 Feb 20251 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
24 Feb 20251 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
3
Supplier Names

Baxter Healthcare Ltd

ITH Pharma Limited

Qualasept Limited t/a Bath ASU

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...